Dr. Hao Ding is the Manager, Group Products at IMO, where he leads the development of advanced AI and natural language processing (NLP) solutions tailored to the healthcare industry. Prior to IMO he was the Director of Operations at Melax Tech and held postdoctoral research positions at the University of Texas Health Science Center at Houston and Rice University. His research focused on applying optical imaging techniques like Raman spectroscopy and fluorescence microscopy to cancer detection and other biomedical applications. Dr. Ding earned his PhD in Biophysics from the University of Michigan. In addition to his passion for NLP, machine learning, and the impact of new technologies on improving healthcare, Dr. Ding enjoys spending time with his family and staying active at the gym.
